Food and Drug Administration (FDA) Regulatory Compliance Training
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- PANDHA-25-P-002528
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Place of performance
- Frederick, Maryland 21702, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The U.S. Army Medical Research and Development Command (USAMRDC) is seeking a contractor to provide regulatory compliance training for personnel involved in FDA-regulated research activities. The Defense Health Agency will oversee this procurement, which focuses on training in Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP), and Quality Systems Regulations (QSR). The primary objective is to maintain and increase competency among research personnel to ensure compliance with FDA, Department of Defense, and Army regulations governing product development. Vendors must be registered in SAM.gov and submit capability statements limited to five pages, including company information, point of contact details, Unique Entity ID, CAGE code, and business size status. The response deadline is February 5, 2025, at 4:00 PM ET, with responses to be submitted electronically to Matthew Gembe.
The contract is not set aside for any specific business category and will be structured as a Firm-Fixed-Price agreement with a base year and four one-year option periods. Training will be delivered both virtually via Microsoft Teams and face-to-face at Fort Detrick, Maryland, with class sizes limited to 30 participants for in-person sessions and 40 for virtual sessions. The anticipated contract period begins approximately May 1, 2025, with approximately 4-8 training sessions annually across various disciplines. Contractors will be required to provide both introductory (8-hour) and refresher (4-hour) courses, develop comprehensive training materials, and submit detailed documentation including draft materials, attendance records, and completion certificates. The training supports USAMRDC's mission of providing FDA-approved pharmaceuticals, devices, and biologics to U.S. Military members, as mandated by Command Policy Memorandum 2013-60.
Notice text
This requirement provides competency training for personnel involved in FDA regulated research activities. The USAMRDC requires FDA regulated training in the areas of Good Clinical Practices (GCP), Good Laboratory Practices (GLP), current Good Manufacturing Practices (cGMP) and Quality Systems Regulations (QSR).
Background:
The purpose of USAMRDC research and development activities is to provide FDA-approved pharmaceuticals and devices or licensed biologics to members of the United States (U.S) Military. These activities are governed by Federal, Department of Defense (DoD), and Army regulation and result in submissions to the FDA for eventual approval or licensure. Those research and development activities are subject to the compliance requirements of the FDA. The requirements defined in Title 21, Code of Federal Regulations (21 CFR), parts 50, 58, 211, 600, and 820, require all individuals engaged in the conduct or supervision of FDA-regulated studies have education, training, and experience, or a combination thereof, to enable the individual to perform the assigned functions. Therefore, the Command must have in place, as part of its Quality efforts, a compliance program that includes minimum standards for training of all personnel involved in FDA-regulated activities. Training requirements are outlined in accordance with USAMRDC Command Policy Memorandum 2013-60 Requirement for Training of Personnel Involved in FDA-Regulated Activities.
The USAMRDC Headquarters Principal Acquisition Assistant serves as the FDA regulated Sponsor Representative, the responsibility for fulfilling FDA regulated sponsor responsibilities, and providing this training for other Subordinate Commands. USAMRDC ORA will provide technical oversight, guidance, and management of this requirement.
Objective:
Assist personnel involved in FDA regulated product development throughout USAMRDC in maintaining competency in GCP, GLP, and cGMP to comply with U.S FDA and all other applicable DoD and Army regulations, directives, and guidance. The long-term objective of this training is to increase and maintain competency and compliance with FDA regulations governing product development efforts to meet our mission.
Files
| File | Type | Posted |
|---|---|---|
| USAMRDC FDA regulatory Compliance Training RFI-Sources Sought.doc | DOC document | |
| A02. FDA Compliance Training_Performance Work Statement.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Food and Drug Administration (FDA) Regulatory Compliance Training | Award Notice | |
| Food and Drug Administration (FDA) Regulatory Compliance Training | Solicitation | |
| This notice | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity